Head-To-Head Contrast: Niagen Bioscience (NASDAQ:NAGE) vs. Coty (NYSE:COTY)

Niagen Bioscience (NASDAQ:NAGE) and Coty (NYSE:COTY) are both consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

Earnings & Valuation

This table compares Niagen Bioscience and Coty”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Niagen Bioscience	$129.42 million	1.84	$17.38 million	$0.18	16.61
Coty	$5.81 billion	0.37	-$604.80 million	($0.70)	-3.46

Niagen Bioscience has higher earnings, but lower revenue than Coty. Coty is trading at a lower price-to-earnings ratio than Niagen Bioscience, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

15.4% of Niagen Bioscience shares are owned by institutional investors. Comparatively, 42.4% of Coty shares are owned by institutional investors. 10.0% of Niagen Bioscience shares are owned by insiders. Comparatively, 5.9% of Coty shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Niagen Bioscience and Coty, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Niagen Bioscience	0	1	3	1	3.00
Coty	2	11	0	0	1.85

Niagen Bioscience currently has a consensus price target of $10.33, suggesting a potential upside of 245.60%. Coty has a consensus price target of $3.24, suggesting a potential upside of 33.65%. Given Niagen Bioscience’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Niagen Bioscience is more favorable than Coty.

Profitability

This table compares Niagen Bioscience and Coty’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Niagen Bioscience	12.39%	17.95%	13.17%
Coty	-10.42%	5.68%	1.82%

Risk & Volatility

Niagen Bioscience has a beta of 2.09, meaning that its stock price is 109% more volatile than the S&P 500. Comparatively, Coty has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500.

Summary

Niagen Bioscience beats Coty on 13 of the 15 factors compared between the two stocks.

About Niagen Bioscience

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

About Coty

Coty Inc., together with its subsidiaries, manufactures, markets, distributes, and sells beauty products worldwide. It operates through Prestige and Consumer Beauty segments. The company provides fragrance, color cosmetics, and skin and body care products. It offers Prestige segment products primarily through prestige retailers, including perfumeries, department stores, e-retailers, direct-to-consumer websites, and duty-free shops under the Burberry, Calvin Klein, Chloe, Davidoff, Escada, Gucci, Hugo Boss, Jil Sander, Joop!, Kylie Jenner, Lancaster, Marc Jacobs, Miu Miu, Orveda, philosophy, SKKN BY KIM, and Tiffany & Co. brands. The company provides Consumer Beauty segment products primarily through hypermarkets, supermarkets, drug stores, pharmacies, mid-tier department stores, traditional food and drug retailers, and e-commerce retailers under the Adidas, Beckham, Biocolor, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, Max Factor, Mexx, Monange, Nautica, Paixao, Rimmel, Risque, and Sally Hansen brands. It also sells its products through third-party distributors. The company was founded in 1904 and is headquartered in New York, New York. Coty Inc. is a subsidiary of JAB Beauty B.V.